Next Article in Journal
In Vitro and In Vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs
Previous Article in Journal
Chemical Composition, Antifungal and Antitumor Properties of Ether Extracts of Scapania verrucosa Heeg. and its Endophytic Fungus Chaetomium fusiforme
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 13
Issue 9
10.3390/molecules13092126
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones

by
Olcay Bekircan
1,* and
Hakan Bektas
1
1
Department of Chemistry, Karadeniz Technical University, 61080 Trabzon, Turkey
2
Department of Chemistry, Giresun University, 28049 Giresun, Turkey
*
Author to whom correspondence should be addressed.
Molecules 2008, 13(9), 2126-2135; https://doi.org/10.3390/molecules13092126
Submission received: 15 August 2008 / Revised: 28 August 2008 / Accepted: 1 September 2008 / Published: 10 September 2008
Browse Figure
Versions Notes

Abstract

:
Ethyl imidate hydrochlorides 1 were prepared by passing HCl gas through solutions of substituted benzyl cyanides and absolute ethanol. Ethoxycarbonylhydrazones 2 were synthesized from the reaction of compounds 1 with ethyl carbazate. Treatment of 2 with hydrazine hydrate leads to the formation of substituted 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones 3. Isatin and 5-chloroisatin were added to 3 to form Schiff bases 4 and N-Mannich bases 5 of these compounds were synthesized by reacting with formaldehyde and piperidine. Their chemical structures were confirmed by means of IR, 1H- and 13C-NMR data and by elemental analysis.

Introduction

Schiff bases are used as substrates in the preparation of a number of industrial and biologically active compounds via ring closure, cycloaddition and replacement reactions [1]. Moreover, Schiff bases derived from various heterocycles have been reported to possess cytotoxic [2], anticonvulsant [3], antiproliferative [4], antimicrobial [5], anticancer [6], and antifungal activities [7]. Mannich bases have gained importance due to their application in pharmaceutical chemistry. They have been encountered with antibacterial [8], anticancer [9], analgesic and anti-inflammatory [10], anticonvulsant [11], antimalarial [12], antiviral [13], and CNS depressant activities [14]. Isatin, chemically known as 1H-indole-2,3-dione, has become a popular topic due to its various uses. The chemistry of isatin and its derivatives is particularly interesting because of their potential application in medicinal chemistry. Isatins are very important compounds due to their antifungal properties [15]. Schiff and Mannich bases of isatin derivatives are reported to show variety of biological activities like antibacterial [16], antifungal [17], anticonvulsant [18], anti HIV [19], antidepressant [20], and antiinflammatory [21] activities. Similarly, 1,2,4-triazoles and their derivatives play important roles in medicinal, agricultural and industrial fields [22,23,24,25]. N-bridged heterocyclic derivatives derived from 1,2,4-triazoles show varied biological activities such as antimicrobial [26], anticonvulsant [27], anticancer [28], analgesic [29], anti HIV [30], and anti-inflammatory properties [31].
These biological data prompted us to synthesize new isatin derivatives bearing 1,2,4-triazole ring and the newly synthesized compounds were characterized by elemental analysis, IR, 1H- and 13C-NMR spectral data.

Results and Discussion

In the present study, ethyl imidate hydrochlorides 1 were prepared by passing HCl gas through solutions of o- or p-fluorobenzyl cyanide in absolute ethanol, followed by precipitation with ether. Ester ethoxycarbonyl hydrazones 2 were synthesized by the reactions of alkyl imidate hydrochlorides 1 with ethyl carbazate. Treatment of compounds 2 with hydrazine hydrate in water resulted in the formation of 3-o-fluorobenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3a) and 3-p-fluorobenzyl-4-amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3b), respectively. The substituted 4-amino-4,5-dihydro-1H-1,2,4-triazoles 3 were condensed with isatin derivatives in the presence of a few drops of glacial acetic acid as a catalyst to produce Schiff bases 4 in rather good yields. Mannich base formation can take place at both the isatin and triazole NH protons, but it is known that the isatin NH proton is more active than the triazole one [32]. In addition, after the Mannich reactions, the 1H- NMR spectra of compounds 5 show NH proton signals at around δ 11.00 ppm, which correspond to a triazole NH, so we conclude that in the current study, Mannich bases were formed by condensing the acidic imino group of isatin with formaldehyde and piperidine, instead of the triazole NH proton (Scheme 1).
Compounds 2 showed absorption bands at around 3277, 1720, and 1659 cm-1 regions, resulting from the NH, C=O, and C=N functions, respectively. Compounds 3 showed two peaks at around 3220 and 3165 cm-1 due to asymmetric and symmetric vibrations of the primary amino group. Compounds 4 and 5 showed two separate bands belonging to triazole indole C=O functions in the 1733-1750 and 1698-1710 cm-1 regions, and C=N stretching vibrations at around 1650 cm-1. In the IR spectra of 5, triazole NH stretching vibrations were around 3200 cm-1. The characteristic NH protons of compounds 2 were detected around δ 9.00 ppm. The characteristic NH2 protons of compounds 3 were detected around δ 5.00 ppm. The 1H-NMR spectra of 4 displayed the NH protons of the triazole moiety (δ 11.07-11.17 ppm) and the indole NH proton (δ 12.09-12.53) as two separate singlets. Compounds 5 displayed characteristic >N-CH2-N< signals at around δ 4.36 ppm (s, 2H, CH2).
Molecules 13 02126 g001 550
Scheme 1. Synthetic pathway for preparation of compounds 1 and 5.
Scheme 1. Synthetic pathway for preparation of compounds 1 and 5.
Molecules 13 02126 g001
In the 13C-NMR spectra of compounds 2a-b characteristic C=O signals appeared at around δ 171.00 ppm. The triazole C-3 and triazole C-5 signals of compounds 3a-b were recorded at δ 149.38 ppm (C-3) and δ 156.33 ppm (C-5). Characteristic triazole and indole C=O and the C=N carbon signals of compounds 4a-d were recorded at around δ 150 ppm, δ 165 ppm, and δ 150 ppm, respectively. In the 13C-NMR spectra of compounds 5a-d characteristic >N-CH2-N< signals belonging to the Mannich bases were observed at around δ 171.00 ppm.

Conclusions

It is known that the heterocycle compounds containing both 1,2,4-triazole and isatin rings have diverse pharmacologic properties [15,16,17,18,19,20,25,26,27,28,29,30,31,33]. A general and convenient method was established for the synthesis of new heterocyclic compounds bearing these two rings. Thus, two new ester ethoxycarbonyl hydrazones 2, two new amino compounds 3, and eight new Schiff and Mannich bases of isatin and 5-chloro isatin with substituted 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones 4-5 were synthesized in good yields. Compounds 4-5 are expected to exhibit biological activities.

Experimental

General

Melting points were determined on a Barnstead Electrothermal melting point apparatus and are uncorrected. 1H-NMR and 13C-NMR spectra (δ, ppm) were recorded in DMSO-d6 solutions on a Varian-Mercury 200 MHz spectrometer using tetramethylsilane as the internal reference. The IR spectra (υ, cm-1) were obtained with a Perkin-Elmer 1600 FTIR spectrometer in KBr pellets. Elemental analyses were performed on a ECS 4010 Elemental Combustion System. The starting compounds, alkyl imidate hydrochlorides 1a-b, were synthesized by previously reported routes [34,35]. The necessary chemicals were purchased from Merck and Fluka companies.

Synthesis of Ethoxycarbonyl Hydrazones 2a-b

The corresponding ethyl imidate hydrochlorides (1a-b, 0.01 mol) was dissolved in absolute ethanol (50 mL) with ice-bath cooling, and ethyl carbazate (0.01 mol) dissolved in absolute ethanol (50 mL) was then added to this solution. After stirring for 6 h at 0-5 °C, the precipitate was filtered to remove the ammonium chloride which separated from the solution and the filtrate was evaporated at 30-35 °C under reduced pressure. The solid residue, after drying in a dessicator, was recrystallized from petroleum ether to yield compounds 2a-b.
Ethyl o-fluorophenylacetate ethoxycarbonyl hydrazone (2a): Yield 82%, m.p. 48-49 °C; IR υ (cm-1): 3277 (NH), 1720 (C=O), 1650 (C=N), 758 (1,2-disubstituted phenyl); 1H-NMR δ (ppm): 1.10-1.20 (m, 6H, 2CH3), 3.74 (s, 2H, benzyl CH2), 3.96-4.09 (m, 4H, 2CH2), 7.11-7.29 (m, 4H, Ar-H), 9.37 (s, 1H, NH); 13C-NMR δ (ppm): 15.70 (O=COCH2CH3), 16.38 (OCH2CH3), 29.55 (benzyl CH2), 61.96 (O=COCH2CH3), 63.59 (OCH2CH3), Ar-C: [115.58, 124.35, 125.00, 126.32, 130.79, 156.19], 163.11 (C=N), 171.92 (C=O); Calculated (%) for C13H17FN2O3 (268.29); C: 58.20, H: 6.39, N: 10.44, found (%); C: 58.18, H: 6.40, N: 10.45.
Ethyl p-fluorophenylacetate ethoxycarbonyl hydrazone (2b): Yield 80%, m.p. 58-59 °C; IR υ (cm-1): 3226 (NH), 1724 (C=O), 1659 (C=N), 837 (1,4-disubstituted phenyl); 1H-NMR δ (ppm): 1.11-1.18 (m, 6H, 2CH3), 3.45 (s, 2H, benzyl CH2), 4.00-4.06 (m, 4H, 2CH2), 7.07 (d, 2H, J= 8.80 Hz, Ar-H), 7.21 (d, 2H, J= 8.80 Hz, Ar-H), 9.08 (s, 1H, NH); 13C-NMR δ (ppm): 14.72 (O=COCH2CH3), 15.22 (OCH2CH3), 21.39 (benzyl CH2), 60.44 (O=COCH2CH3), 60.93 (OCH2CH3), Ar-C: [115.55 (2C), 130.85 (2C), 133.19, 160.39], 162.79 (C=N), 171.87 (C=O); Calculated (%) for C13H17FN2O3 (268.29); C: 58.20, H: 6.39, N: 10.44, found (%);C: 58.22, H: 6.40, N: 10.47.

Synthesis of Amino Compounds 3a-b

Compounds 2 (0.01 mol) were added to a solution of hydrazine hydrate (0.01 mol) in water (50 mL) and the mixture was refluxed for 5 h. On cooling, a precipitate was formed. This product was filtered and, after drying, was recrystallized from an appropriate solvent to give compounds 3a-b.
3-o-Fluorobenzyl-4-Amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3a): Recrystallized from water; Yield 87%; m.p. 158-159 °C; IR υ (cm-1): 3316 (NH), 3220-3164 (NH2), 1726 (C=O), 1652 (C=N), 764 (1,2-disubstituted phenyl); 1H-NMR δ= 3.91 (s, 2H, benzyl CH2), 5.21 (s, 2H, NH2), 7.11-7.36 (m, 4H, Ar-H), 11.44 (s, 1H, NH); 13C-NMR δ= 25.87 (benzyl CH2), Ar-C: [116.68, 124.65, 121.11, 130.50, 132.92, 164.60], 149.38 (triazole C-3), 156.35 (triazole C-5); Calculated (%) for C9H9FN4O (208.20); C: 51.92, H: 4.36, N: 26.91, found (%);C: 51.82, H: 4.36, N: 26.96.
3-p-Fluorobenzyl-4-Amino-4,5-dihydro-1H-1,2,4-triazole-5-one (3b): Recrystallized from ethanol-water (1:2); Yield 82%; m.p. 182-183 °C; IR υ (cm-1): 3318 (NH), 3223-3165 (NH2), 1729 (C=O), 1644 (C=N), 844 (1,4-disubstituted phenyl); 1H-NMR δ= 3.86 (s, 2H, benzyl CH2), 4.60 (s, 2H, NH2), 7.13 (d, 2H, J= 6.4 Hz, Ar-H), 7.32 (d, 2H, J= 6.4 Hz, Ar-H), 11.43 (s, 1H, NH); 13C-NMR δ= 31.61 (benzyl CH2), Ar-C: [116.60 (2C), 132.31 (2C), 134.01, 165.27], 149.38 (triazole C-3), 156.33 (triazole C-5); Calculated (%) for C9H9FN4O (208.20); C: 51.92, H: 4.36, N: 26.91, found (%);C: 51.90, H: 4.35, N:26.94.

Synthesis of Schiff Bases 4a-d

Equimolar quantities (0.01 mol) of isatin or 5-chloroisatin and the corresponding amino compound 3a-b were dissolved in warm ethanol (50 mL) containing glacial acetic acid (0.5 mL). The reaction mixture was refluxed for 4 h and then kept at room temperature overnight. The resultant solid was washed with dilute ethanol, dried and recrystallized from ethanol-water (1:2) mixture to afford compounds 4a-d.
3-[3-(o-Fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-iminoisatin (4a): Yield 78%; obtained as yellowish crystals; m.p. 278-279 °C; IR υ (cm-1): 3182, 3087 (NH), 1750 (triazole C=O), 1709 (isatin C=O), 754 (1,2-disubstituted phenyl); 1H-NMR δ= 4.02 (s, 2H, benzyl CH2), Ar-H: [ 6.88-6.99 (m, 1H), 7.02-7.15 (m, 4H), 7.20-7.36 (m, 2H), 7.43-7.50 (m, 1H) ], 11.07 (s, 1H, triazole NH), 12.11 (s, 1H, isatin NH) ppm; 13C-NMR δ= 27.03 (benzyl CH2), Ar-C: [116.72, 123.4, 123.73, 126.07, 130.98, 159.75], indole-C: [ 112.92, 117.56, 124.12, 131.04, 133.21, 137.27 (C=N), 146.66, 165.00 (C=O)], 147.96 (triazole C-3), 150.94 (triazole C-5) ppm; Calculated (%) for C17H12FN5O2 (337.31); C: 60.53, H: 3.59, N: 20.76, found (%);C: 60.54, H: 3.81, N: 20.64.
3-[3-(p-Fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-iminoisatin (4b): Yield 82%; obtained as yellow-orange crystals; m.p. 253-254 °C; IR υ (cm-1): 3175, 3089 (NH), 1733 (triazole C=O), 1710 (isatin C=O), 842 (1,4-disubstituted phenyl); 1H-NMR δ= 4.00 (s, 2H, benzyl CH2), Ar-H: [ 6.90-7.09 (m, 5H), 7.25-7.32 (m, 2H), 7.42-7.50 (m, 1H) ], 11.15 (s, 1H, triazole NH), 12.20 (s, 1H, isatin NH) ppm; 13C-NMR δ= 32.51 (benzyl CH2), Ar-C: [116.61 (2C), 132.52 (2C), 132.99, 159.27], indole-C: [112.91, 117.03, 124.11, 129.71, 132.46, 137.26 (C=N), 147.65, 165.01 (C=O)], 147.91(triazole C-3), 150.73 (triazole C-5) ppm; Calculated (%) for C17H12FN5O2 (337.31); C: 60.53, H: 3.59, N: 20.76, found (%);C: 60.54, H: 3.58, N: 20.74.
3-[3-(o-Fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-imino-5-chloro-isatin (4c): Yield 85%; obtained as orange crystals; m.p. 302-303 °C; IR υ (cm-1): 3203, 3080 (NH), 1747 (triazole C=O), 1701 (isatin C=O), 755 (1,2-disubstituted phenyl); 1H-NMR δ= 4.04 (s, 2H, benzyl CH2), Ar-H: [6.93-6.96 (m, 1H), 7.10-7.27 (m, 2H), 7.29-7.37 (m, 2H), 7.54-7.64 (m, 2H)], 11.17 (s, 1H, triazole NH), 12.09 (s, 1H, isatin NH) ppm; 13C-NMR δ= 26.95 (benzyl CH2), Ar-C: [116.73, 123.47, 124.29, 126.07, 130.99, 159.99], indole-C: [114.56, 122.30, 128.38, 131.07, 133.11, 136.36 (C=N), 145.46, 162.87 (C=O)], 145.94 (triazole C-3), 150.46 (triazole C-5) ppm; Calculated (%) for C17H11ClFN5O2 (371.76); C: 54.92, H: 2.98, N: 18.84, found (%);C: 54.94, H: 2.98, N:18.80.
3-[3-(p-Fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-imino-5-chloro-isatin (4d): Yield 80%; obtained as orange crystals; m.p. 194-195 °C; IR υ (cm-1): 3193, 3078 (NH), 1750 (triazole C=O), 1698 (isatin C=O), 841 (1,4-disubstituted phenyl); 1H-NMR δ= 3.96 (s, 2H, benzyl CH2), Ar-H: [6.93-7.13 (m, 3H), 7.28-7.35 (m, 2H), 7.56-7.66 (m, 2H)], 11.15 (s, 1H, triazole NH), 12.53 (s, 1H, isatin NH) ppm; 13C-NMR δ= 31.61 (benzyl CH2), Ar-C: [115.61 (2C), 132.48 (2C), 133.87, 155.32], indole-C: [117.03, 120.92, 125.92, 128.04, 132.33, 134.09 (C=N), 139.10, 160.92 (C=O)], 149.38 (triazole C-3), 150.93 (triazole C-5) ppm; Calculated (%) for C17H11ClFN5O2 (371.76); C: 54.92, H: 2.98, N: 18.84, found (%);C: 54.96, H: 2.66, N:18.72.

Synthesis of Mannich Bases 5a-d

The corresponding Schiff bases 4a-d (0.002 mol) were dissolved in absolute ethanol (100 mL). Then formaldehyde (37%, 0.5 mL) and piperidine (0.002 mol) were added dropwise with vigorous stirring. After combining all reagents, the reaction mixture was stirred at room temperature for 12 h. The mixture was cooled, the solid product was filtered and washed with petroleum ether. The solid that separated was recrystallized from ethanol-dioxane (1:2) to yield the title compounds 5a-d.
1-Piperidinomethyl-3-[3-(o-fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-iminoisatin (5a): Yield 72%; obtained as yellow crystals; m.p. 115-116 °C; IR υ (cm-1): 3247 (NH), 2936 (aliphatic CH2), 1745 (triazole C=O), 1709 (isatin C=O), 757 (1,2-disubstituted phenyl); 1H-NMR δ= 1.45 (br, s, 6H, piperidine 3CH2), 2.51 (br, s, 4H, piperidine 2CH2), 4.01 (s, 2H, benzyl CH2), 4.36 (s, 2H, N-CH2-N), 6.91-7.11 (m, 3H, Ar-H), 7.26-7.30 (m, 2H, Ar-H), 7.50-7.70 (m, 3H, Ar-H), 11.16 (s, 1H, triazole NH) ppm; 13C-NMR δ= 25.40 (piperidine C), 27.12 (piperidine 2C), 31.28 (benzyl CH2), 52.93 (piperidine 2C), 69.32 (N-CH2-N), Ar-C: [115.65, 125.40, 125.99, 127.74, 128.63, 161.00], indole-C: [117.20, 120.98, 126.04, 129.41, 130.99, 139.07 (C=N), 146.88, 164.54 (C=O)], 147.27 (triazole C-3), 151.04 (triazole C-5) ppm; Calculated (%) for C23H23FN6O2 (434.47); C: 63.58, H: 5.34, N: 19.34, found (%);C: 63.19, H: 5.33, N:19.54.
1-Piperidinomethyl-3-[3-(p-fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-iminoisatin (5b): Yield 65%; obtained as yellow crystals; m.p. 141-142 °C; IR υ (cm-1): 3236 (NH), 2936 (aliphatic CH2), 1740 (triazole C=O), 1705 (isatin C=O), 856 (1,4-disubstituted phenyl); 1H-NMR δ= 1.46 (br, s, 6H, piperidine 3CH2), 2.50 (br, s, 4H, piperidine 2CH2), 4.00 (s, 2H, benzyl CH2), 4.59 (s, 2H, N-CH2-N), 6.93-7.07 (m, 5H, Ar-H), 7.23-7.30 (m, 2H, Ar-H), 7.42-7.50 (m, 1H, Ar-H), 11.11 (s, 1H, triazole NH) ppm; 13C-NMR δ= 25.39 (piperidine C), 27.33 (piperidine 2C), 32.40 (benzyl CH2), 52.75 (piperidine 2C), 69.37 (N-CH2-N), Ar-C: [116.62 (2C), 129.99 (2C), 132.36, 159.77], indole-C: [117.09, 123.91, 124.45, 129.37, 132.53, 137.52 (C=N), 148.09, 164.46 (C=O)], 149.55 (triazole C-3), 154.90 (triazole C-5) ppm; Calculated (%) for C23H23FN6O2 (434.47); C: 63.58, H: 5.34, N: 19.34, found (%);C: 63.58, H: 5.36, N:19.36.
1-Piperidinomethyl-3-[3-(o-fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-imino-5-chloroisatin (5c): Yield 64%; obtained as reddish-orange crystals; m.p. 155-156 °C; IR υ (cm-1): 3224 (NH), 2935 (aliphatic CH2), 1748 (triazole C=O), 1708 (isatin C=O), 756 (1,2-disubstituted phenyl); 1H-NMR δ= 1.22 (br, s, 6H, piperidine 3CH2), 2.26 (br, s, 4H, piperidine 2CH2), 3.82 (s, 2H, benzyl CH2), 4.35 (s, 2H, N-CH2-N), 6.99-7.04 (m, 5H, Ar-H), 7.28-7.34 (m, 2H, Ar-H), 11.13 (s, 1H, triazole NH) ppm; 13C-NMR δ= 25.30 (piperidine C), 27.40 (piperidine 2C), 31.24 (benzyl CH2), 52.50 (piperidine 2C), 69.67 (N-CH2-N), Ar-C: [116.57, 124.06, 124.16, 125.98, 130.64, 159.66], indole-C: [117.09, 123.75, 130.49, 132.94, 133.00, 139.73 (C=N), 146.26, 164.55 (C=O) ], 146.33 (triazole C-3), 154.54 (triazole C-5) ppm; Calculated (%) for C23H22ClFN6O2 (468.92); C: 58.91, H: 4.73, N: 17.92, found (%);C: 58.64, H: 4.70, N: 17.86.
1-Piperidinomethyl-3-[3-(p-fluorobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazol-1-yl]-imino-5-chloroisatin (5d): Yield 67%; obtained as reddish-orange crystals; m.p. 126-127 °C; IR υ (cm-1): 3251 (NH), 2937 (aliphatic CH2), 1748 (triazole C=O), 1708 (isatin C=O), 846 (1,4-disubstituted phenyl); 1H-NMR δ= 1.46 (br, s, 6H, piperidine 3CH2), 2.51 (br, s, 4H, piperidine 2CH2), 4.02 (s, 2H, benzyl CH2), 4.36 (s, 2H, N-CH2-N), 6.91-7.11 (m, 3H, Ar-H), 7.26-7.30 (m, 2H, Ar-H), 7.50-7.70 (m, 2H, Ar-H), 11.16 (s, 1H, triazole NH) ppm; 13C-NMR δ= 25.40 (piperidine C), 27.26 (piperidine 2C), 32.11 (benzyl CH2), 52.69 (piperidine 2C), 69.45(N-CH2-N), Ar-C: [115.59 (2C), 125.97 (2C), 132.66, 160.99], indole-C: [117.10, 120.87, 125.40, 128.55, 132.45, 139.67 (C=N), 146.85, 164.87 (C=O)], 149.17 (triazole C-3), 151.07 (triazole C-5); Calculated (%) for C23H22ClFN6O2 (468.92); C: 58.91, H: 4.73, N: 17.92, found (%);C: 58.95, H: 4.71, N:17.95.

Acknowledgements

This work was supported by Karadeniz Technical University Research Fund (Project No: 2004.122.002.01).

References and Notes

  1. Karia, F.D.; Parsania, P.H. Synthesis, biological and thermal properties of schiff bases of bisphenol-C. Asian J. Chem. 1999, 11, 991–995. [Google Scholar]
  2. Tarafder, M.T.; Kasbollah, A.; Saravan, N.; Crouse, K.A.; Ali, A.M.; Tin, O.K. S-methyldithiocarbazate and its schiff bases: Evaluation of bondings and biological properties. J. Biochem. Mol. Biol. Biophs. 2002, 6, 85–91. [Google Scholar] [CrossRef]
  3. Küçükgüzel, İ.; Küçükgüzel, Ş.G.; Rollas, S.; Ötük-Sanış, G.; Özdemir, O.; Bayrak, İ.; Altuğ, T.; Stables, J.P. 3-(Arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity. Farmaco. 2004, 59, 893–901. [Google Scholar] [CrossRef]
  4. Vicini, P.; Geronikaki, A.; Incerti, M.; Busonera, B.; Poni, G.; Kabras, C.A.; Colla, P.L. Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. Bioorg. Med. Chem. 2003, 11, 4785–4789. [Google Scholar] [CrossRef]
  5. Kahveci, B.; Bekircan, O.; Karaoglu, SA. Synthesis and antimicrobial activity of some 3-alkyl-4-(arylmethyleneamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones. Indian J. Chem. 2005, 44B, 2614–2617. [Google Scholar]
  6. Bekircan, O.; Kahveci, B.; Kucuk, M. Synthesis and anticancer evaluation of some new unsymmetrical 3,5-diaryl-4H-1,2,4-triazole derivatives. Tur. J. Chem. 2006, 30, 29–40. [Google Scholar]
  7. Singh, W.M.; Dash, B.C. Synthesis of some new schiff bases containing thiazole and oxazole nuclei and their fungicidal activity. Pesticides 1988, 22, 33–37. [Google Scholar]
  8. Holla, B.S.; Shivananda, M.K.; Shenoy, M.S.; Antony, G. Synthesis and characterization of some mannich bases carrying halophenylfuryl moieties as promising antibacterial agents. Farmaco. 1998, 53, 531–535. [Google Scholar] [CrossRef]
  9. Holla, B.S.; Veerendra, B.; Shivananda, M.K.; Poojary, B. Synthesis characterization and anticancer activity studies on some mannich bases derived from 1,2,4-triazoles. Eur. J. Med. Chem. 2003, 38, 759–767. [Google Scholar]
  10. Gokce, E.; Bakir, G.; Sahin, M.F.; Kupeli, E.; Yesilada, E. Synthesis of new mannich bases of arylpyridazinones as analgesic and anti-inflammatory agents. Arzneim. Forsch. 2005, 55, 318–325. [Google Scholar]
  11. Dimmock, J.R.; Jonnalagadda, S.S.; Phillips, O.A.; Erciyas, E.; Shyam, K.; Semple, H.A. Anticonvulsant properties of some mannich bases of conjugated arylidene ketones. J. Pharm. Sci. 1992, 81, 436–440. [Google Scholar] [CrossRef]
  12. Lopes, F.; Capela, R.; Goncaves, J.O.; Horton, P.N.; Hursthouse, M.B.; Iley, J.; Casimiro, C.M.; Bom, J.; Moreire, R. Amidomethylation of amodiaquine: antimalarial N-mannich base derivatives. Tetrahedron Lett. 2004, 45, 7663–7666. [Google Scholar] [CrossRef]
  13. Sriram, D.; Bal, T.R.; Yogeesswari, P. Synthesis, antiviral and antibacterial activities of isatin mannich bases. Med. Chem. Res. 2005, 14, 11–28. [Google Scholar]
  14. Knabe, J.; Buch, H.P.; Schmitt, W. Derivatives of barbituric acid cytostatic and CNS activities of chiral barbiturate mannich-bases. Arch. Pharm. Chem. Life Sci. 1983, 316, 1051–1053. [Google Scholar] [CrossRef]
  15. Islam, M.R.; Abedin, M.J.; Hossain, M.M.; Duddeck, H. Synthesis of 1-methyl bis-dioxopyrolino [2,3:2,3:2,3:6,5] benzene and its heterocycles via thiocarbohydrazone, thiosemicarbazone. J. Bangladesh Chem. Soc. 1998, 11, 71–78. [Google Scholar]
  16. Sarangapani, M.; Reddy, V.M. Pharmacological evaluation of 1-(N,N-disubstituted aminomethyl)-3-imino-(2-phenyl-3,4-dihydro-4-oxo-quinazolin-3-yl) indolin-2-ones. Indian J. Pharm. Sci. 1994, 56, 174–177. [Google Scholar]
  17. Pandeya, S.N.; Sriram, D.; Nath, G.; De Clercq, E. Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives. Pharm. Acta Helv. 1999, 74, 11–17. [Google Scholar] [CrossRef]
  18. Popp, F.D.; Parson, R.; Donigan, B.E. Potential anticonvulsants the condensation of isatin with cyclic-ketones. J. Heterocycl. Chem. 1980, 17, 1329–1330. [Google Scholar] [CrossRef]
  19. Pandeya, S.N.; Sriram, D.; DeClercq, E.; Nath, G. Synthesis, antibacterial, antifungal and anti-HIV activities of schiff and mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl]thiosemicarbazide. Eur. J. Pharm. Sci. 1999, 9, 25–31. [Google Scholar] [CrossRef]
  20. Singh, G.S.; Singh, T.; Lakhan, R. Synthesis 13C-NMR and anticonvulsant activity of new isatin-based spiroazetidinones. Indian J. Chem. 1997, 36B, 951–954. [Google Scholar]
  21. Bhattacharya, S.K.; Chakrabarti, S. Dose-related proconvulsant and anticonvulsant activity of isatin, a putative biological factor in rats. Indian J. Exp. Biol. 1998, 36, 118–121. [Google Scholar]
  22. Legrand, C.; Ropaa, P.; Vulturescu, B.; Hogeac, A.M.; Surpateanu, G.G.; Cazier, F.; Woisel, P.; Surpateanu, G. Electrical properties of some 1,2,4-triazole derivatives. Progress in Organic Coatings 2005, 53, 106–111. [Google Scholar] [CrossRef]
  23. Ewiss, N.F.; Bahajaj, A.A.; Elsherbini, E.A. Synthesis of heterocycles, Part VI-Synthesis and antimicrobial activity of some 4-amino-5-aryl-1,2,4-triazole-3-thions and their derivatives. J. Heterocycl. Chem. 1986, 23, 1451–1458. [Google Scholar] [CrossRef]
  24. Eweiss, N.F.; Bahajaj, A.A. Synthesis and antimicrobial activity of some 7H-s-triazolo[3,4-b][1,3,4]thiadiazine and s-triazolotriazolo[3,4-b][1,3,4]thiadiazole Derivatives. J. Heterocycl. Chem. 1987, 24, 1173–1182. [Google Scholar] [CrossRef]
  25. Prasad, A.; Ramalingam, R.J.; Rao, A.B.; Diwan, P.V.; Sattur, P.B. Synthesis and biological evaluation of 3-aryloxyalkyl-6-aryl-7H-s-triazolo[3,4-b][1,3,4]thiadiazines. Eur. J. Med. Chem. 1989, 24, 199–201. [Google Scholar]
  26. Turan-Zitouni, G.; Kaplancıklı, Z.A.; Yıldız, M.T.; Chevallet, P.; Kaya, D. Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]-thio-4H-1,2,4-triazole derivatives. Eur. J. Med. Chem. 2005, 40, 607–613. [Google Scholar]
  27. Chen, J.; Sun, X.Y.; Chai, K.Y.; Lee, J.S.; Song, M.S.; Quan, Z.S. Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolines. Bioorg. Med. Chem. 2007, 15, 6775–6781. [Google Scholar] [CrossRef]
  28. Bekircan, O.; Gumrukcuoglu, N. Synthesis of Some 3,5-diphenyl-4H-1,2,4-triazole derivatives as antitumor agents. Indian J. Chem. 2005, 44B, 2107–2113. [Google Scholar]
  29. Turan-Zitouni, G.; Kaplancıklı, Z.A.; Erol, K.; Kilic, F.S. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco 1999, 54, 218–223. [Google Scholar] [CrossRef]
  30. Akhtar, T.; Hameed, S.; Al-Masoudi, N. A.; Khan, K.M. Synthesis and anti-HIV activity of new chiral 1,2,4-triazoles and 1,3,4-thiadiazoles. Heteroatom. Chem. 2007, 18, 316–322. [Google Scholar] [CrossRef]
  31. Turan-Zitouni, G.; Kaplancikli, Z.A.; Özdemir, A.; Chevallet, P. Studies on 1,2,4-triazole derivatives as potential anti-ıInflammatory agents. Arch. Pharm. Chem. Life Sci. 2007, 340, 586–590. [Google Scholar] [CrossRef]
  32. Pandeya, S.N.; Sriram, D.; Nath, G.; de Clercq, E. Synthesis, antibacterial, antifungal and anti HIV evaluation of schiff and mannich bases of isatin and its derivatives with triazole. Arzneimittel Forsch. 2000, 50, 55–59. [Google Scholar]
  33. Kahveci, B. Synthesis of 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones and their isatin-3-imine derivatives. Molecules 2005, 10, 376–382. [Google Scholar] [CrossRef]
  34. Kelley, J.L.; Linn, J.A.; Bankston, D.D.; Burchall, C.J.; Soroko, F.E.; Cooper, B.R. 8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity. J. Med. Chem. 1995, 38, 3676–3679. [Google Scholar] [CrossRef]
  35. Huang, Z.; Liu, Z. Synthesis of 2-(Benzoylmethylene)imidazolidines and hexahydropyrimidines by condensation of ethyl benzoylacetimidates with 1,2-ethanediamine or 1,3-propandiamine, and some addition Reactions. Synthesis 1987, 4, 357–362. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds are available from authors

Share and Cite

MDPI and ACS Style

Bekircan, O.; Bektas, H. Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones. Molecules 2008, 13, 2126-2135. https://doi.org/10.3390/molecules13092126

AMA Style

Bekircan O, Bektas H. Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones. Molecules. 2008; 13(9):2126-2135. https://doi.org/10.3390/molecules13092126

Chicago/Turabian Style

Bekircan, Olcay, and Hakan Bektas. 2008. "Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones" Molecules 13, no. 9: 2126-2135. https://doi.org/10.3390/molecules13092126

APA Style

Bekircan, O., & Bektas, H. (2008). Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones. Molecules, 13(9), 2126-2135. https://doi.org/10.3390/molecules13092126

Article Metrics

Back to TopTop